Ortin Laboratories Ltd.
Snapshot View

23.55 +0.10 ▲0.4%

29 September 2022, 01:55:42 PM
Volume: 14,016

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.ortinlabsindia.com
Market Cap 19.35 Cr.
Enterprise Value(EV) 24.58 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) -1.13 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-06
Industry PE 30.82 Trailing Twelve Months Ending 2022-06
Book Value / Share 12.95 Trailing Twelve Months Ending 2022-06
Price to Book Value 1.84 Calculated using Price: 23.80
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 0.81 Cr. 8,131,392 Shares
FaceValue 10
Company Profile
Ortin Laboratories established in the year 1986 was a private limited company with a nominal capital of Rs 1 lakh to offer quality drugs and medicines to the suffering mankind. Later, in the year 1994, this private limited company converted as a public limited company with 5,060 shareholders which received good subscription from the public. These proceeds were utilised for constructing a factory in a spacious area of 25000 sq feet with all ultra-modern infrastructure as per the WHO GMP Standards to manufacture the complete range of Pharmaceutical Formulations of Tablets, Capsules, Syrups, Dry Powders & Ointments. Due to its concern for quality, the company stands as a leading and predominant pharmaceutical manufacturer of drugs and medicines of the country with turnover running in crores of rupees.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.43%
1 Week
-11.80%
1 Month
+1.73%
3 Month
+10.05%
6 Month
+0.86%
1 Year
-12.78%
2 Year
+16.87%
5 Year
+41.87%
10 Year
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 5.34 5.55 4.04 3.65 2.16 2.86 5.21 -2.31 5.38
Return on Capital Employed (%) 15.05 13.62 11.55 11.01 9.58 10.14 11.76 8.93 3.27
Return on Assets (%) 1.40 1.62 1.28 1.25 0.79 1.00 1.43 -0.51 1.37

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 21 22 22 23 23 24 25 24 11 11
Non Curr. Liab. 4 6 8 16 8 8 8 9 2 2
Curr. Liab. 49 45 37 27 31 42 72 84 8 8
Minority Int.
Equity & Liab. 73 73 68 66 62 74 105 117 21 21
Non Curr. Assets 27 26 24 35 23 21 23 24 15 15
Curr. Assets 46 47 44 31 38 52 82 92 6 6
Misc. Exp. not W/O 0
Total Assets 73 73 68 66 62 74 105 117 21 21

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 75 67 60 63 67 80 168 197 8 9
Other Income 0 1 0 1 0 0 1 0 0 0
Total Income 75 68 61 64 67 80 168 198 8 9
Total Expenditure -68 -61 -54 -57 -61 -74 -162 -192 -7 -9
PBIDT 7 7 7 6 6 6 7 6 1 0
Interest -4 -4 -4 -3 -3 -3 -3 -3 -1 -1
Depreciation -1 -2 -2 -2 -2 -2 -2 -2 0 0
Taxation -1 -1 0 -1 -1 -1 -1 1 0
Exceptional Items
PAT 1 1 1 1 1 1 1 -1 1 -1
Adjusted EPS 1 1 1 0 0 0 1 0 1 -1

Cash Flow View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 0 -2 -2 -1 1 2 2 7 3 18
Cash Fr. Inv. -2 -2 0 0 -1 -1 -1 -3 -3 0
Cash Fr. Finan. 2 5 1 2 0 -1 0 -3 -1 -10
Net Change 0 1 -1 1 0 0 1 0 -1 8
Cash & Cash Eqvt 1 2 1 2 2 -14 -13 -13 -14 -5

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 34.84 34.84 34.84 10.40 15.68 15.68 15.68 15.68 15.68
Public 65.16 65.16 65.16 89.60 84.32 84.32 84.32 84.32 84.32
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 09 Sep 2022
Book Closure
Ortin Laboratories Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 24-Sep-2022 to 30-Sep-2022 for the purpose of Annual general meeting.
Thu, 08 Sep 2022
Book Closure
Ortin Laboratories Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 24-Sep-2022 to 30-Sep-2022 for the purpose of Annual general meeting.
Thu, 18 Aug 2022
Newspaper Advertisements
Ortin Laboratories Limited has informed the Exchange about Newspaper Advertisements for publication of unaudited Financial Results for the quarter ended 30.06.2022.

Technical Scans View Details >>

Wed, 28 Sep 2022
Closing Near 50 SMA Closing Near 50 SMA
Closing Near 100 SMA Closing Near 100 SMA
Close Crossing 50 SMA From Above Close Crossing 50 SMA From Above
ROC Trending Down ROC Trending Down
MFI Above 80 MFI Above 80

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 220,222.96 930.80 +1.4%
Divi's Laboratories Ltd. 98,114.53 3,714.95 +0.3%
Cipla Ltd. 88,495.80 1,117.60 +1.9%
Dr. Reddy's Laboratories Ltd. 71,034.40 4,379.20 +2.6%
Apollo Hospitals Enterprise Ltd. 61,344.29 4,388.05 +2.8%
Torrent Pharmaceuticals Ltd. 50,536.67 1,537.05 +2.9%
Alkem Laboratories Ltd. 39,477.37 3,211.45 -2.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.55 930.80 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-06 31.60 3,714.95 +0.3%
Cipla Ltd. Consolidated 2022-06 35.56 1,117.60 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.75 4,379.20 +2.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 69.44 4,388.05 +2.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 63.09 1,537.05 +2.9%
Alkem Laboratories Ltd. Consolidated 2022-06 30.25 3,211.45 -2.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.39 930.80 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-06 7.89 3,714.95 +0.3%
Cipla Ltd. Consolidated 2022-06 4.12 1,117.60 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.51 4,379.20 +2.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.32 4,388.05 +2.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 7.91 1,537.05 +2.9%
Alkem Laboratories Ltd. Consolidated 2022-06 4.50 3,211.45 -2.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 930.80 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,714.95 +0.3%
Cipla Ltd. Consolidated 2022-03 0.04 1,117.60 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,379.20 +2.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,388.05 +2.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,537.05 +2.9%
Alkem Laboratories Ltd. Consolidated 2022-03 0.30 3,211.45 -2.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 930.80 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,714.95 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 1,117.60 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,379.20 +2.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,388.05 +2.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.05 +2.9%
Alkem Laboratories Ltd. Consolidated 2022-03 20.99 3,211.45 -2.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 930.80 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,714.95 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 1,117.60 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,379.20 +2.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,388.05 +2.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.05 +2.9%
Alkem Laboratories Ltd. Consolidated 2022-03 20.99 3,211.45 -2.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 930.80 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,714.95 +0.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,117.60 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,379.20 +2.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,388.05 +2.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,537.05 +2.9%
Alkem Laboratories Ltd. Consolidated 2022-03 10,634.19 3,211.45 -2.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 930.80 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,714.95 +0.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,117.60 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,379.20 +2.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,388.05 +2.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,537.05 +2.9%
Alkem Laboratories Ltd. Consolidated 2022-03 1,680.32 3,211.45 -2.6%

FAQ's On Ortin Laboratories Ltd.

What is Ortin Laboratories share price?

Can I buy Ortin Laboratories shares now?

What is the Market Cap of Ortin Laboratories?

What are the key metrics to analyse Ortin Laboratories?

What is the 52 Week High and Low of Ortin Laboratories?

What is the trend of Ortin Laboratories share price?